HDL Therapeutics HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis. | ![]() ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | ||
Founding Date | Founding Date N/A | Founding Date 2009 | Founding Date 2002 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Dublin, IE HQ Dublin, IE | Locations Vero Beach, US HQ | Locations San Clemente, US HQ San Clemente, US |
Employees | Employees 838% increase | Employees 7 | Employees 4348% decrease |
Funding | |||
Latest funding round | Latest funding round $ 7.5m (about 10 years ago) | Latest funding round $ 3m (almost 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 7.5m | Total funding raised $ 7.4m | Total funding raised N/A |
HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis.
View company
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View company